文献速递脑血管病

早发性缺血性卒中的外显子阵列分析

Exome Array Analysis of Early-Onset Ischemic Stroke.
PubMed 文献 · Stroke · 2020-09-11

本研究采用两阶段发现与复制设计,在马里兰大学早发性卒中遗传学研究(UMD-GEOS)的723例15-49岁首次缺血性卒中病例和726例非卒中对照中,进行Illumina外显子芯片基因分型,检验常见及低频变异与缺血性卒中及其TOAST亚型的关联。基因负荷检验发现NAT10与小血管性卒中显著相关(P=3.79×10-6),通路分析提示神经递质、Notch信号及脂糖代谢通路可能参与。未见单个SNP达到芯片-wide显著性,但LEXM和TRAPPC11变异接近显著。

要点

  • 外显子芯片分析在早发性卒中中识别出NAT10与小血管性卒中的基因负荷关联。
  • 通路分析提示神经递质、神经发育Notch信号及脂/糖代谢通路可能参与小血管性卒中。
  • 单个SNP未达芯片-wide显著性,LEXM和TRAPPC11变异接近显著。

核心结论

  • 基于外显子的分析是识别早发性卒中新型遗传风险变异、位点和通路的有前景策略。

研究设计与样本

  • 两阶段发现与复制设计,发现阶段在UMD-GEOS研究中进行,纳入723例15-49岁首次缺血性卒中病例和726例非卒中对照,均为既往GWAS参与者并接受Illumina外显子芯片基因分型。

主要发现

  • 基因负荷检验发现NAT10与小血管性卒中显著相关(P=3.79×10-6)。
  • 对小血管性卒中基因分析中前517个基因(P<0.05)的通路分析识别出多个信号和代谢相关通路,涉及神经递质、神经发育Notch信号及脂/糖代谢。
  • 无单个SNP达到芯片-wide显著性(P<2.05×10-7),但LEXM内含子变异(rs7549251;P=4.08×10-7)和TRAPPC11外显子变异(rs67383011;P=5.19×10-6)接近显著。

关键数值与推荐

  • 基因负荷检验中NAT10与小血管性卒中的关联P=3.79×10-6。
  • 芯片-wide显著性阈值定义为P<2.05×10-7。

临床怎么用

  • 外显子芯片分析可用于早发性卒中遗传 risk 变异的探索,NAT10及所识别通路可能为未来机制研究和风险分层提供候选靶点。

局限性

  • 未发现单个SNP达到芯片-wide显著性,关联信号需在更大样本中验证。
  • 复制阶段通过查找既往早发性卒中荟萃分析和以晚发性病例为主的大规模卒中遗传学研究进行,但摘要未报告复制结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The genetic contribution to ischemic stroke may include rare- or low-frequency variants of high-penetrance and large-effect sizes. Analyses focusing on early-onset disease, an extreme-phenotype, and on the exome, the protein-coding portion of genes, may increase the likelihood of identifying such rare functional variants. To evaluate this hypothesis, we implemented a 2-stage discovery and replication design, and then addressed whether the identified variants also associated with older-onset disease. METHODS: Discovery was performed in UMD-GEOS Study (University of Maryland-Genetics of Early-Onset Stroke), a biracial population-based study of first-ever ischemic stroke cases 15 to 49 years of age (n=723) and nonstroke controls (n=726). All participants had prior GWAS (Genome Wide Association Study) and underwent Illumina exome-chip genotyping. Logistic-regression was performed to test single-variant associations with all-ischemic stroke and TOAST (Trial of ORG 10172 in Acute Stroke Treatment) subtypes in Whites and Blacks. Population level results were combined using meta-analysis. Gene-based aggregation testing and meta-analysis were performed using seqMeta. Covariates included age and gender, and principal-components for population structure. Pathway analyses were performed across all nominally associated genes for each stroke outcome. Replication was attempted through lookups in a previously reported meta-analysis of early-onset stroke and a large-scale stroke genetics study consisting of primarily older-onset cases. RESULTS: Gene burden tests identified a significant association with NAT10 in small-vessel stroke (P=3.79×10-6). Pathway analysis of the top 517 genes (P<0.05) from the gene-based analysis of small-vessel stroke identified several signaling and metabolism-related pathways related to neurotransmitter, neurodevelopmental notch-signaling, and lipid/glucose metabolism. While no individual SNPs reached chip-wide significance (P<2.05×10-7), several were near, including an intronic variant in LEXM (rs7549251; P=4.08×10-7) and an exonic variant in TRAPPC11 (rs67383011; P=5.19×10-6). CONCLUSIONS: Exome-based analysis in the setting of early-onset stroke is a promising strategy for identifying novel genetic risk variants, loci, and pathways.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jaworek T, Ryan KA, Gaynor BJ, et al. Exome Array Analysis of Early-Onset Ischemic Stroke. Stroke. 2020. PMID: 32912094. doi:10.1161/STROKEAHA.120.031357

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。